Nagarjuna Herbal Concentrates Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Nagarjuna Herbal Concentrates Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $18.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nagarjuna Herbal Concentrates Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $18.4K Trade | TransData Nexus

Nagarjuna Herbal Concentrates Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $18.4K Total Trade · DGFT Verified

Nagarjuna Herbal Concentrates Limited is an Indian pharmaceutical exporter with a total trade value of $18.4K across 2 products in 1 therapeutic categories. Based on 82 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Arishta ($11.8K), Asava ($6.6K), .

Nagarjuna Herbal Concentrates Limited — Export Portfolio & Destination Treemap

Nagarjuna Herbal Concentrates Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Nagarjuna Herbal Concentrates Limited? — Company Overview & Market Position

Nagarjuna Herbal Concentrates Limited (NHCL), established on June 12, 1986, is a prominent Indian pharmaceutical company specializing in the manufacturing and marketing of Ayurvedic and herbal products. The company is registered under the Corporate Identification Number (CIN) U24239KL1986PLC004504 and is headquartered in Thodupuzha, Idukki District, Kerala, India.

NHCL operates as a public unlisted company with an authorized capital of ₹50 million and a paid-up capital of ₹26.48 million. The company's product portfolio includes over 450 items, encompassing traditional Ayurvedic medicines, proprietary formulations, and over-the-counter (OTC) herbal products. These products are distributed across 19 states in India and exported to 22 countries worldwide.

What Does Nagarjuna Herbal Concentrates Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Arishta$11.8K 2Asava$6.6K

Product Portfolio — Top 2 by Export Value

Nagarjuna Herbal Concentrates Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Arishta	Ayurvedic & Herbal Products	$11.8K	48	0.8%	15
2	Asava	Ayurvedic & Herbal Products	$6.6K	34	0.8%	11

Nagarjuna Herbal Concentrates Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $18.4K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Nagarjuna Herbal Concentrates Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

NHCL's manufacturing facility is located in Kalayanthani P.O., Thodupuzha, Idukki District, Kerala, India. The plant is equipped with modern technology and equipment, including Chromatographic Finger Printing (CFP) for standardizing raw materials and equipment to test heavy metal contents in both raw materials and finished products.

3Key Leadership

The leadership team at NHCL comprises several key individuals:

Vadakkillom Godan Namboodiripad Devadasnamboodiripad
Vadakkillom Godan Jathavedan
Venkat Subrahmanyam Nanduri
Michael Joseph Kalariparambil
Krishnakumar Subrahmanian Namboodiri Cherumanal Mana

These individuals hold various positions within the company, contributing to its strategic direction and operational success.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Nagarjuna Herbal Concentrates Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

NHCL's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's export activities are primarily focused on Ayurvedic and herbal products, which may face regulatory challenges in these markets due to stringent standards for pharmaceutical products. NHCL's manufacturing facility holds Good Manufacturing Practices (GMP) certification, indicating adherence to quality standards, but specific regulatory approvals for these markets are not specified.

2Emerging Markets

NHCL exports its products to 22 countries, including regions in Africa, Latin America, and Southeast Asia. While the company does not explicitly mention WHO prequalification, its adherence to GMP standards and the Department of Scientific and Industrial Research (DSIR) approval for its R&D laboratory suggest a commitment to quality that may facilitate access to these emerging markets.

3Geographic Strategy

NHCL's export strategy demonstrates a focus on both domestic and international markets, with a significant presence in 19 Indian states and exports to 22 countries. This approach indicates a balanced diversification strategy, reducing reliance on any single market and mitigating concentration risk. The company's strategic direction appears to be geared towards expanding its footprint in both established and emerging markets, leveraging its expertise in Ayurvedic and herbal products.

Nagarjuna Herbal Concentrates Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding NHCL's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history is not available in the provided sources. Given the nature of NHCL's product portfolio, which focuses on Ayurvedic and herbal formulations, it is possible that the company does not have FDA approvals for its products, as these are often subject to different regulatory pathways compared to conventional pharmaceuticals.

2WHO & EU GMP

NHCL's manufacturing facility is certified for Good Manufacturing Practices (GMP), indicating compliance with quality standards. However, specific certifications such as WHO prequalification or EU GMP certificates are not explicitly mentioned in the available sources. The company's adherence to GMP standards and approval by the Department of Scientific and Industrial Research (DSIR) for its R&D laboratory suggest a commitment to quality that may align with international standards.

3CDSCO & Indian Regulatory

Nagarjuna Herbal Concentrates Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

NHCL operates in the Ayurvedic and herbal product segment, competing with other manufacturers in this niche market. While specific competitors are not identified in the available sources, the company's extensive product portfolio and established distribution network position it as a significant player in the Indian market. The focus on quality, as evidenced by GMP certification and DSIR approval, provides NHCL with a competitive edge in both domestic and international markets.

2Key Differentiators

NHCL's unique strengths include its comprehensive product portfolio of over 450 Ayurvedic and herbal products, a robust distribution network across 19 Indian states, and export operations in 22 countries. The company's commitment to quality is demonstrated through its GMP certification and DSIR-approved R&D laboratory. Additionally, NHCL's integration of traditional Ayurvedic practices with contemporary science and its focus on holistic healthcare solutions distinguish it in the market.

3Strategic Position

NHCL's current strategic direction emphasizes the manufacturing and marketing of Ayurvedic and herbal products, with a focus on both domestic and international markets. The company's adherence to quality standards and its extensive product portfolio suggest a strategy aimed at expanding its market presence and leveraging the growing global interest in natural and holistic healthcare solutions. Future outlooks may include further diversification of product offerings and exploration of new markets to sustain growth and competitiveness.

Buyer Due Diligence Brief — Evaluating Nagarjuna Herbal Concentrates Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

NHCL's track record in manufacturing Ayurvedic and herbal products is supported by its GMP certification and approvals from regulatory bodies such as the CDSCO and DSIR. The company's export volume and consistency are evidenced by its presence in 22 countries, indicating reliable supply capabilities. The establishment of over 1,000 retail outlets across India further demonstrates NHCL's commitment to meeting market demand and ensuring product availability.

2Certifications to Verify

Importers should verify the following certifications when considering NHCL as a supplier:

Good Manufacturing Practices (GMP) Certification: Indicates compliance with quality manufacturing standards.
Department of Scientific and Industrial Research (DSIR) Approval: Confirms the company's R&D laboratory meets government standards.
Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) Registration: Ensures ethical standards in animal testing.

Frequently Asked Questions — Nagarjuna Herbal Concentrates Limited

How many pharmaceutical products does Nagarjuna Herbal Concentrates Limited export from India?

Nagarjuna Herbal Concentrates Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Arishta ($11.8K), Asava ($6.6K). Total export value is $18.4K.

What is Nagarjuna Herbal Concentrates Limited's total pharmaceutical export value?

Nagarjuna Herbal Concentrates Limited's total pharmaceutical export value is $18.4K, based on 82 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Nagarjuna Herbal Concentrates Limited cover?

Nagarjuna Herbal Concentrates Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Nagarjuna Herbal Concentrates Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.